{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,31]],"date-time":"2025-08-31T18:10:13Z","timestamp":1756663813644,"version":"3.44.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,8,31]]},"DOI":"10.7759\/cureus.91346","type":"journal-article","created":{"date-parts":[[2025,8,31]],"date-time":"2025-08-31T17:43:55Z","timestamp":1756662235000},"source":"Crossref","is-referenced-by-count":0,"title":["Angiotensin-Converting Enzyme Inhibitor-Induced Angioedema Following Long-Term Lisinopril Use: Response to C1 Esterase Inhibitor Treatment"],"prefix":"10.7759","author":[{"given":"Zaid","family":"Mula Hussein","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammed Emran","family":"Khan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ashfaque","family":"Sorathia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kithsri","family":"Karunatilake","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.2014.138","article-title":"Phenotype standardization of angioedema in the head and neck region caused by agents acting on the angiotensin system","volume":"96","author":"Wadelius M","year":"2014","unstructured":"Wadelius M, Marshall SE, Islander G, et al.. Phenotype standardization of angioedema in the head and neck region caused by agents acting on the angiotensin system. Clin Pharmacol Ther. 2014, 96:477-81. 10.1038\/clpt.2014.138","journal-title":"Clin Pharmacol Ther"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.108.111393","article-title":"Angiotensin-converting enzyme inhibitors and angioedema: estimating the risk","volume":"51","author":"Weber MA","year":"2008","unstructured":"Weber MA, Messerli FH. Angiotensin-converting enzyme inhibitors and angioedema: estimating the risk. Hypertension. 2008, 51:6. 10.1161\/HYPERTENSIONAHA.108.111393","journal-title":"Hypertension"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1097\/TME.0000000000000211","article-title":"Treatment of life-threatening ACE-inhibitor-induced angioedema","volume":"40","author":"Hirschy R","year":"2018","unstructured":"Hirschy R, Shah T, Davis T, Rech MA. Treatment of life-threatening ACE-inhibitor-induced angioedema. Adv Emerg Nurs J. 2018, 40:267-77. 10.1097\/TME.0000000000000211","journal-title":"Adv Emerg Nurs J"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1007\/s11906-018-0859-x","article-title":"ACE inhibitor-induced angioedema: a review","volume":"20","author":"Kostis WJ","year":"2018","unstructured":"Kostis WJ, Shetty M, Chowdhury YS, Kostis JB. ACE inhibitor-induced angioedema: a review. Curr Hypertens Rep. 2018, 20:55. 10.1007\/s11906-018-0859-x","journal-title":"Curr Hypertens Rep"},{"key":"ref5","article-title":"Treatment of severe ACE inhibitor angioedema: current and future therapies","volume":"56","author":"Alchakaki A","year":"2016","unstructured":"Alchakaki A, Salem D. Treatment of severe ACE inhibitor angioedema: current and future therapies. Consultant. 2016, 56:","journal-title":"Consultant"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1007\/s40521-019-0203-y","article-title":"Current treatment of angioedema induced by ACE inhibitors","volume":"6","author":"Terreehorst I","year":"2019","unstructured":"Terreehorst I, Reitsma S, Cohn DM. Current treatment of angioedema induced by ACE inhibitors. Curr Treat Options Allergy. 2019, 6:18-26. 10.1007\/s40521-019-0203-y","journal-title":"Curr Treat Options Allergy"},{"key":"ref7","unstructured":"Angioedema. (2011). Accessed. May 18, 2025: https:\/\/www.rcemlearning.co.uk\/reference\/angioedema\/."},{"key":"ref8","unstructured":"Angioedema. (2022). Accessed. May 18, 2025: https:\/\/wikem.org\/wiki\/Angioedema."},{"key":"ref9","doi-asserted-by":"crossref","DOI":"10.1017\/cem.2016.21","article-title":"Icatibant compared to steroids and antihistamines for ACE-inhibitor-induced angioedema","volume":"19","author":"Botnaru T","year":"2017","unstructured":"Botnaru T, Robert A, Mottillo S. Icatibant compared to steroids and antihistamines for ACE-inhibitor-induced angioedema. CJEM. 2017, 19:159-62.","journal-title":"CJEM"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.23736\/S2532-1285.22.00133-1","article-title":"Use of C1 esterase inhibitor (Berinert\u00ae) for ACE inhibitor-induced angioedema at the emergency department","volume":"11","author":"Giordano S","year":"2022","unstructured":"Giordano S, Tiozzo G, Tiozzo A. Use of C1 esterase inhibitor (Berinert\u00ae) for ACE inhibitor-induced angioedema at the emergency department. Ital J Emerg Med. 2022, 11:119-22. 10.23736\/S2532-1285.22.00133-1","journal-title":"Ital J Emerg Med"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.4082\/kjfm.21.0095","article-title":"Angiotensin-converting enzyme inhibitor-induced non-allergic perioral angioedema: a case-based scoping review","volume":"44","author":"Pitak-Arnnop P","year":"2023","unstructured":"Pitak-Arnnop P, Subbalekha K, Muangchan C, Auychai P, Sirintawat N, Meningaud JP, Neff A. Angiotensin-converting enzyme inhibitor-induced non-allergic perioral angioedema: a case-based scoping review. Korean J Fam Med. 2023, 44:2-10. 10.4082\/kjfm.21.0095","journal-title":"Korean J Fam Med"},{"key":"ref12","unstructured":"ACE inhibitor-induced angioedema. (2020). Accessed. May 18, 2025: https:\/\/dermnetnz.org\/topics\/ace-inhibitor-induced-angioedema."},{"key":"ref13","article-title":"ACEI associated angioedema: a case study and review","volume":"40","author":"Andrew N","year":"2011","unstructured":"Andrew N, Gabb G, Del Fante M. ACEI associated angioedema: a case study and review. Aust Fam Physician. 2011, 40:985-8.","journal-title":"Aust Fam Physician"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1186\/s13256-018-1910-x","article-title":"Perindopril-induced angioedema of the lips and tongue: a case report","volume":"12","author":"Alharbi FA","year":"2018","unstructured":"Alharbi FA, Alharthi AA, Alsaadi FN. Perindopril-induced angioedema of the lips and tongue: a case report. J Med Case Rep. 2018, 12:359. 10.1186\/s13256-018-1910-x","journal-title":"J Med Case Rep"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2004.09.032","article-title":"Angioedema","volume":"53","author":"Kaplan AP","year":"2005","unstructured":"Kaplan AP, Greaves MW. Angioedema. J Am Acad Dermatol. 2005, 53:373-88; quiz 389-92. 10.1016\/j.jaad.2004.09.032","journal-title":"J Am Acad Dermatol"},{"key":"ref16","article-title":"Angioneurotic edema","author":"Ohn MH","year":"2023","unstructured":"Ohn MH, Wadhwa R. Angioneurotic edema. StatPearls [Internet]. StatPearls Publishing, Treasure Island (FL); 2023."},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1997.03550030072037","article-title":"Recurrent angiotensin-converting enzyme inhibitor-associated angioedema","volume":"278","author":"Brown NJ","year":"1997","unstructured":"Brown NJ, Snowden M, Griffin MR. Recurrent angiotensin-converting enzyme inhibitor-associated angioedema. JAMA. 1997, 278:232-3. 10.1001\/jama.1997.03550030072037","journal-title":"JAMA"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1186\/s13223-024-00934-3","article-title":"Angioedema","volume":"20","author":"Lacuesta G","year":"2024","unstructured":"Lacuesta G, Betschel SD, Tsai E, Kim H. Angioedema. Allergy Asthma Clin Immunol. 2024, 20:65. 10.1186\/s13223-024-00934-3","journal-title":"Allergy Asthma Clin Immunol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1111\/all.15214","article-title":"The international WAO\/EAACI guideline for the management of hereditary angioedema - the 2021 revision and update","volume":"77","author":"Maurer M","year":"2022","unstructured":"Maurer M, Magerl M, Betschel S, et al.. The international WAO\/EAACI guideline for the management of hereditary angioedema - the 2021 revision and update. Allergy. 2022, 77:1961-90. 10.1111\/all.15214","journal-title":"Allergy"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.18203\/2319-2003.ijbcp20233911","article-title":"A case report on angioedema induced by ramipril in a patient treated in a tertiary care hospital in north India","volume":"13","author":"Sankalp","year":"2023","unstructured":"Sankalp, Tewari S. A case report on angioedema induced by ramipril in a patient treated in a tertiary care hospital in north India. Int J Basic Clin Pharmacol. 2023, 13:170-3. 10.18203\/2319-2003.ijbcp20233911","journal-title":"Int J Basic Clin Pharmacol"},{"key":"ref21","article-title":"ACE inhibitor-induced angioedema: a case report and review of current management","volume":"13","author":"Kloth N","year":"2011","unstructured":"Kloth N, Lane AS. ACE inhibitor-induced angioedema: a case report and review of current management. Crit Care Resusc. 2011, 13:33-7.","journal-title":"Crit Care Resusc"},{"key":"ref22","article-title":"ACEI-associated angioedema: a case study and review","volume":"40","author":"Andrew N","year":"2011","unstructured":"Andrew N, Gabb G, Del Fante M. ACEI-associated angioedema: a case study and review. Aust Fam Physician. 2011, 40:985-8.","journal-title":"Aust Fam Physician"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc1503671","article-title":"Icatibant in ACE-inhibitor-induced angioedema","volume":"372","author":"Armengol G","year":"2015","unstructured":"Armengol G, Faisant C, Benhamou Y. Icatibant in ACE-inhibitor-induced angioedema. N Engl J Med. 2015, 372:1867. 10.1056\/NEJMc1503671","journal-title":"N Engl J Med"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.4168\/aair.2010.2.3.195","article-title":"Angiotensin-converting enzyme inhibitors and angioedema","volume":"2","author":"S\u00e1nchez-Borges M","year":"2010","unstructured":"S\u00e1nchez-Borges M, Gonz\u00e1lez-Aveledo LA. Angiotensin-converting enzyme inhibitors and angioedema. Allergy Asthma Immunol Res. 2010, 2:195-8. 10.4168\/aair.2010.2.3.195","journal-title":"Allergy Asthma Immunol Res"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1186\/s13223-021-00521-w","article-title":"Effectiveness of C1-INH therapy in angiotensin converting enzyme inhibitor induced angioedema","volume":"17","author":"Kovaltchouk U","year":"2021","unstructured":"Kovaltchouk U, Zhang B, Jain V, Kalicinsky C. Effectiveness of C1-INH therapy in angiotensin converting enzyme inhibitor induced angioedema. Allergy Asthma Clin Immunol. 2021, 17:18. 10.1186\/s13223-021-00521-w","journal-title":"Allergy Asthma Clin Immunol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/376862-angiotensin-converting-enzyme-inhibitor-induced-angioedema-following-long-term-lisinopril-use-response-to-c1-esterase-inhibitor-treatment","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,31]],"date-time":"2025-08-31T17:43:58Z","timestamp":1756662238000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/376862-angiotensin-converting-enzyme-inhibitor-induced-angioedema-following-long-term-lisinopril-use-response-to-c1-esterase-inhibitor-treatment"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,31]]},"references-count":25,"URL":"https:\/\/doi.org\/10.7759\/cureus.91346","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8,31]]}}}